Safety: Clinical Trials

5 trials for Safety, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Unknown 5
Phase 22Unknown 2

Follow Safety: new trials by email Literature Review of Safety trials Research Report on Safety

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer
Fluzoparib, Apatinib Mesylate - Epithelial Ovarian Cancer, Efficacy
Phase 3UnknownAnhui Provincial Hospital512024-10-012024-08-06
A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2
Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2; - Immunogenicity, Safety
Phase 2 / Phase 3UnknownStemirna Therapeutics8002023-06-202023-06-20
mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs
SW-BIC-213;SARS-Cov-2., Sinopharm (BIBP);SARS-Cov-2., Pfizer(BNT162b2);SARS-Cov-2. - Immunogenicity, Safety
Phase 3UnknownStemirna Therapeutics6002022-10-192023-01-17
New Generation mRNA Booster Vaccine Against Emerging VOCs
SW-BIC-213, SARS-Cov-2 Vaccina(Vero Cell ) Inactivated - Immunogenicity, Efficacy
Phase 3UnknownStemirna Therapeutics20002022-10-012023-04-12
Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA Patients
Advixa (Adalimumab) - Pharmacokinetics, Safety
Phase 2 / Phase 3UnknownInstitute for Developing Science and Health Initiatives, Bangladesh2002021-06-022022-07-07

Narrower conditions

Arthritis, Rheumatoid (1)  ·  Carcinoma, Ovarian Epithelial (1)

Broader conditions

Adnexal Diseases (1)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Carcinoma (1)  ·  Connective Tissue Diseases (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Gonadal Disorders (1)  ·  Immune System Diseases (1)  ·  Joint Diseases (1)

Interventions

Adalimumab (1)  ·  apatinib (1)  ·  fluzoparib (1)

Sponsors

Stemirna Therapeutics (3)  ·  Anhui Provincial Hospital (1)  ·  Institute for Developing Science and Health Initiatives, Bangladesh (1)

Countries

Laos (2)  ·  Bangladesh (1)

Top investigators

Mayfong Mayxay, doctor (3)  ·  Ying Zhou, MD (1)  ·  Zannat Kawser, M.Phil. (1)

Results publications

PMID 38169790